Position in JNJ
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$5,836,230
+$850,143 QoQ
Shares Held
22,980
+12.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.53%
of 13F equity value
Holder Rank
#1,500
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RFG Advisory, LLC holds $46,810,911 across 13 Drug Manufacturers - General names. JNJ ranks #3 (12.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,775 | $12,923,859 | |
| 2 | ABBV |
AbbVie Inc.
|
40,584 | $10,212,557 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
22,980 | $5,836,230 | |
| 4 | AMGN |
Amgen Inc
|
14,031 | $5,080,905 | |
| 5 | NVO |
Novo Nordisk A S
|
66,135 | $3,170,511 | |
| 6 | MRK |
Merck & Co., Inc.
|
20,666 | $2,655,581 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
35,462 | $2,043,320 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
12,955 | $1,636,734 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,836,230 | 22,980 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $4,986,087 | 20,398 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $3,950,882 | 19,091 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $3,455,301 | 18,635 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,611,566 | 17,097 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $3,031,223 | 18,278 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $2,424,265 | 16,763 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $2,604,628 | 16,072 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $2,703,083 | 18,494 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $2,714,224 | 17,158 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $2,895,614 | 18,474 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $2,921,558 | 18,758 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $2,756,901 | 16,656 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $3,894,065 | 25,123 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $4,016,667 | 22,738 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $3,664,818 | 22,434 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $3,876,818 | 21,840 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $4,115,457 | 23,221 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $4,009,880 | 23,440 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $3,198,507 | 19,805 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $3,244,224 | 19,693 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $3,235,887 | 19,689 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $3,110,773 | 19,766 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $2,895,418 | 19,448 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $2,608,827 | 18,551 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $2,354,963 | 17,959 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||